Here are the top 10 costliest specialty drugs in 2014:
Name, use, average 30-day supply cost
1. Sovaldi, pill to treat hepatitis C, $28,083*
2. Stelara, injection to treat psoriasis, $11,131
3. Gleevec, pill to treat leukemia and other cancers, $10,893
4. Gilenya, pill to treat multiple sclerosis, $6,743
5. Copaxone, injection to treat multiple sclerosis, $6,623
6. Tecfidera, pill to treat multiple sclerosis, $6,407
7. Humira, injection to treat rheumatoid arthritis, $3,890
8. Enbrel, injection to treat rheumatoid arthritis, $3,674
9. Atripla, pill to treat HIV, $2,853
10. Abilify, pill to treat psychiatric disorders, $1,011
Researchers used the Truven Health MarketScan Commercial Database to analyze prescriptions purchased by commercially insured patients, and defined specialty drugs using CMS’s threshold, which designates a product costing $600 or more for a 30-day supply as a specialty drug.
*Sovaldi is usually taken only for 12 weeks with at least one other medicine. Other listed drugs are typically taken for years until they become ineffective or the patient switches treatment.
More articles on payer issues:
87% of individuals keep coverage purchased on public exchanges
40,000 to lose coverage after Conn. officials deem co-op unstable
Illinois regulators move to protect Land of Lincoln policyholders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
